R Squared LTD Zentalis Pharmaceuticals, Inc. Transaction History
R Squared LTD
- $181 Billion
- Q2 2025
A detailed history of R Squared LTD transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, R Squared LTD holds 10,808 shares of ZNTL stock, worth $15,563. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,808Holding current value
$15,563% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ZNTL
# of Institutions
138Shares Held
60.8MCall Options Held
7.9KPut Options Held
42.5K-
Matrix Capital Management Company, LP Waltham, MA14MShares$20.1 Million6.94% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$6.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$4.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.07MShares$4.42 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.8MShares$4.03 Million0.01% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $82.1M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...